» Articles » PMID: 38177508

MEnrich-seq: Methylation-guided Enrichment Sequencing of Bacterial Taxa of Interest from Microbiome

Overview
Journal Nat Methods
Date 2024 Jan 4
PMID 38177508
Authors
Affiliations
Soon will be listed here.
Abstract

Metagenomics has enabled the comprehensive study of microbiomes. However, many applications would benefit from a method that sequences specific bacterial taxa of interest, but not most background taxa. We developed mEnrich-seq (in which 'm' stands for methylation and seq for sequencing) for enriching taxa of interest from metagenomic DNA before sequencing. The core idea is to exploit the self versus nonself differentiation by natural bacterial DNA methylation and rationally choose methylation-sensitive restriction enzymes, individually or in combination, to deplete host and background taxa while enriching targeted taxa. This idea is integrated with library preparation procedures and applied in several applications to enrich (up to 117-fold) pathogenic or beneficial bacteria from human urine and fecal samples, including species that are hard to culture or of low abundance. We assessed 4,601 bacterial strains with mapped methylomes so far and showed broad applicability of mEnrich-seq. mEnrich-seq provides microbiome researchers with a versatile and cost-effective approach for selective sequencing of diverse taxa of interest.

Citing Articles

Critical assessment of nanopore sequencing for the detection of multiple forms of DNA modifications.

Kong Y, Zhang Y, Mead E, Chen H, Loo C, Fan Y bioRxiv. 2024; .

PMID: 39605700 PMC: 11601653. DOI: 10.1101/2024.11.19.624260.


Emerging methylation-based approaches in microbiome engineering.

Won C, Yim S Biotechnol Biofuels Bioprod. 2024; 17(1):96.

PMID: 38987811 PMC: 11238421. DOI: 10.1186/s13068-024-02529-x.


Restriction Endonuclease-Based Modification-Dependent Enrichment (REMoDE) of DNA for Metagenomic Sequencing.

Enam S, Cherry J, Leonard S, Zheludev I, Lipman D, Fire A Appl Environ Microbiol. 2022; 89(1):e0167022.

PMID: 36519847 PMC: 9888230. DOI: 10.1128/aem.01670-22.

References
1.
Lynch S, Pedersen O . The Human Intestinal Microbiome in Health and Disease. N Engl J Med. 2016; 375(24):2369-2379. DOI: 10.1056/NEJMra1600266. View

2.
Cho I, Blaser M . The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012; 13(4):260-70. PMC: 3418802. DOI: 10.1038/nrg3182. View

3.
Pryor R, Martinez-Martinez D, Quintaneiro L, Cabreiro F . The Role of the Microbiome in Drug Response. Annu Rev Pharmacol Toxicol. 2019; 60:417-435. DOI: 10.1146/annurev-pharmtox-010919-023612. View

4.
Hedin C, McCarthy N, Louis P, Farquharson F, McCartney S, Taylor K . Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn's disease and their unaffected siblings. Gut. 2014; 63(10):1578-86. DOI: 10.1136/gutjnl-2013-306226. View

5.
Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F . A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012; 490(7418):55-60. DOI: 10.1038/nature11450. View